Haematological disorders

Applied filters

Haematological disorders

COVID-19 Medicines Optimisation (3)
- COVID-19 Medicines Optimisation: Information and resources (1)
- COVID-19 Medicines Optimisation: Specialty Guidance (1)
COVID-19 Vaccines (1)
- General information and guidance (1)
  - Answers to questions for all vaccines (1)
Care Setting (6)
- Emergency medicine and urgent care (1)
- Mental Health (2)
- Primary Care (1)
- Trusts (3)
Events (1)
- Webinars (1)
Guidance (81)
- Administration (4)
- Dosing (4)
- Interactions (1)
- Safety in Breastfeeding (51)
- Stability in dosette boxes (40)
- Stability outside the fridge (23)
Interest areas (2)
- Medicines Safety (2)
Medicine (122)
- Agalsidase alfa (1)
- Albumin human (1)
- Alfacalcidol (1)
- Alglucosidase alfa (1)
- Aluminium hydroxide (1)
- Anagrelide (1)
- Apixaban (3)
- Ascorbic acid (1)
- Calcitriol (1)
- Calcium acetate (1)
- Calcium carbonate (1)
- Calcium polystyrene sulfonate (1)
- Carglumic acid (1)
- Carnitine (1)
- Celiprolol (1)
- Cinacalcet (1)
- Colecalciferol (1)
- Cyanocobalamin (2)
- Dabigatran etexilate (3)
- Dalteparin (3)
- Darbepoetin alfa (1)
- Deferasirox (1)
- Deferiprone (1)
- Eculizumab (1)
- Edoxaban (2)
- Eltrombopag (1)
- Emicizumab (1)
- Enoxaparin (4)
- Epoetin alfa (2)
- Epoetin beta (2)
- Epoetin zeta (1)
- Ergocalciferol (1)
- Factor VIII + von Willebrand factor (1)
- Ferric carboxymaltose (1)
- Ferrous fumarate (1)
- Ferrous gluconate (1)
- Ferrous sulfate (1)
- Ferumoxytol (1)
- Fibrinogen (1)
- Fibrinogen + Thrombin (1)
- Filgrastim (1)
- Fluoxetine (1)
- Folic acid (1)
- Fostamatinib (1)
- Galsulfase (1)
- Haem arginate (1)
- Hydroxocobalamin (4)
- Hydroxycarbamide (1)
- Idarucizumab (2)
- Idursulfase (1)
- Imiglucerase (1)
- Iron dextran (2)
- Iron isomaltoside 1000 (1)
- Iron sucrose (1)
- Lanthanum carbonate (1)
- Laronidase (1)
- Lenograstim (1)
- Lipegfilgrastim (1)
- Magnesium sulfate (1)
- Menadiol (1)
- Mercaptamine (1)
- Methoxy polyethylene glycol-epoetin beta (1)
- Miglustat (1)
- Nicotinamide (1)
- Nitisinone (1)
- Octocog alfa (1)
- Paricalcitol (1)
- Pegfilgrastim (1)
- Penicillamine (1)
- Phosphate (1)
- Phytomenadione (1)
- Plerixafor (1)
- Polysaccharide-iron complex (1)
- Potassium chloride (1)
- Pyridoxine (1)
- Riboflavin (1)
- Rivaroxaban (3)
- Romiplostim (1)
- Rurioctocog alfa pegol (1)
- Selenium (1)
- Sertraline (1)
- Sevelamer (1)
- Simoctocog alfa (1)
- Simvastatin + Ezetimibe (1)
- Sodium bicarbonate (1)
- Sodium chloride (1)
- Sodium phenylbutyrate (1)
- St. John's wort (1)
- Thiamine (1)
- Tinzaparin (3)
- Trientine (1)
- Turoctocog alfa (2)
- Velaglucerase alfa (1)
- Warfarin (1)
- Zinc (1)
- Zinc acetate (1)
Networks (1)
- Antimicrobial resistance networks (1)
Planning (83)
- Advanced therapy medicinal products (9)
- Biosimilars (2)
- New Medicines (65)
  - CCG commissioned new medicines (10)
  - NHS England commissioned new medicines (49)
  - Pre-registration new medicines (UK/EU) (7)
- Patent expiries (35)
Publications (3)
- Bulletins and summaries (3)
Specialty (147)
- Allergy and immunology (1)
- Cancers (3)
- Cardiovascular system disorders (7)
- Ear, nose and throat disorders (2)
- Eyes and vision (5)
- Gastrointestinal disorders (2)
- Haematological disorders (147)
- Infection and infectious diseases (1)
- Mental health and illness (1)
- Musculo-skeletal disorders (4)
- Nutritional and metabolic disorders (47)
- Obstetrics and gynaecology (1)
- Renal and urologic disorders (8)
- Respiratory disorders (2)
- Skin disorders (4)
- Surgery (3)
- Travel Medicine (1)

Using COVID-19 vaccines in patients with anticoagulation and bleeding disorders

7 January 2021Information on use of the vaccine in patients who are receiving anticoagulants or have a bleeding disorder is given below.

Summary of COVID-19 medicines guidance: Haematological disorders

6 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and haematological disorders. Our advice…

Marstacimab

28 November 2020dm+d: Unassigned

New Medicines

CAEL-101

25 November 2020dm+d: Unassigned

New Medicines

Summary of NICE guidance for Anaemia management in people with CKD

13 November 2020This edition of NICE Bites reflects current NICE guidance (as at November 2020). Please go to NICE to check for any updates to this guideline.…

Summary of NICE guidance for Golimumab / Romiplostim / Psychosis with substance misuse / Opioid detoxification

3 November 2020This edition of NICE Bites reflects current NICE guidance (as at November 2020). Please go to NICE to check for any recent updates to this…

Summary of NICE guidance for Neutropenic sepsis

20 October 2020Since this edition of NICE Bites was published, NICE has updated their guideline to reflect MHRA restrictions and precautions for the use of fluoroquinolone antibiotics…

MUS Webinar – Update on NICE VTE Management Guidance & Safer Use of Anticoagulation in Primary Care

14 October 2020In this webinar, Frances and Alison outlined important issues from World Thrombosis week and key points from the NICE VTE guidelines (NG158, March 2020) and…

Oral vitamin B12 – what are the prescribing considerations and what formulations are available?

29 June 2020This Medicines Q&A outlines what oral vitamin B12 (cyanocobalamin) preparations are available and associated prescribing considerations. Hydroxocobalamin 1mg administered intramuscularly (IM) is the preferred method…

How should severe vitamin B12 deficiency in pregnancy be managed?

17 June 2020This updated Medicines Q&A evaluates the limited evidence available on the management of severe vitamin B12 deficiency in pregnancy

SPS - Specialist Pharmacy Service

NHS